Pharming (PHAR) Gross Margin (2020 - 2025)
Historic Gross Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 106.88%.
- Pharming's Gross Margin rose 159900.0% to 106.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 89.9%, marking a year-over-year increase of 12300.0%. This contributed to the annual value of 88.09% for FY2024, which is 16300.0% down from last year.
- Pharming's Gross Margin amounted to 106.88% in Q3 2025, which was up 159900.0% from 89.96% recorded in Q2 2025.
- Pharming's Gross Margin's 5-year high stood at 244.23% during Q3 2021, with a 5-year trough of 84.91% in Q1 2024.
- In the last 5 years, Pharming's Gross Margin had a median value of 89.91% in 2021 and averaged 99.61%.
- Its Gross Margin has fluctuated over the past 5 years, first soared by 1547100bps in 2021, then crashed by -1484700bps in 2022.
- Pharming's Gross Margin (Quarter) stood at 89.91% in 2021, then dropped by -2bps to 88.46% in 2022, then increased by 3bps to 91.26% in 2023, then decreased by -5bps to 86.82% in 2024, then rose by 23bps to 106.88% in 2025.
- Its Gross Margin stands at 106.88% for Q3 2025, versus 89.96% for Q2 2025 and 89.48% for Q1 2025.